Saturna Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,613
Closed -$209K 151
2025
Q4
$209K Hold
13,613
﹤0.01% 149
2025
Q3
$135K Hold
13,613
﹤0.01% 156
2025
Q2
$135K Hold
13,613
﹤0.01% 156
2025
Q1
$177K Hold
13,613
﹤0.01% 148
2024
Q4
$174K Buy
+13,613
New +$165K ﹤0.01% 156

Other funds holding DVAX

Saturna Capital's DVAX Position: Q1 2026 in Review

Saturna Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 13,613 shares — an estimated $209K sold.

Saturna Capital first reported a position in DVAX in Q4 2024 and held it in 5 quarters. The position peaked at $209K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Saturna Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Saturna Capital sold 13,613 Dynavax Technologies shares in Q1 2026, an estimated $209K.
  • Saturna Capital first reported a position in Dynavax Technologies in Q4 2024 and held it in 5 quarters.
  • Saturna Capital's Dynavax Technologies position peaked at $209K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Saturna Capital's 13F filing for Q1 2026, filed 12 May 2026.